Does Rallies show DARE price targets?

Yes. Rallies tracks DARE analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is DARE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for DARE. It does not provide personalized investment advice.

DARE (Dare Bioscience, Inc. Common Stock) Stock Analysis - Analyst Ratings

Dare Bioscience, Inc. Common Stock (DARE) is a publicly traded Healthcare sector company. As of May 21, 2026, DARE trades at $2.36 with a market cap of $31.61M and a P/E ratio of -2.46. DARE moved +5.11% today. Year to date, DARE is +17.09%; over the trailing twelve months it is -19.38%. Its 52-week range spans $1.27 to $9.19. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces DARE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate DARE?

2 analysts cover DARE: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $10.00.

DARE Key Metrics

Key financial metrics for DARE
Metric	Value
Price	$2.36
Market Cap	$31.61M
P/E Ratio	-2.46
EPS	$-0.96
Dividend Yield	0.00%
52-Week High	$9.19
52-Week Low	$1.27
Volume	338
Avg Volume	0
Revenue (TTM)	$1.16M
Net Income	$-12.02M
Gross Margin	0.00%

DARE Analyst Consensus

2 analysts cover DARE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.

Latest DARE News

Dare Bioscience to Launch FloraSync LF5 in June, Seeks Additional Funding — May 15, 2026
Daré Bioscience Achieves Second Positive Ovaprene DSMB Review, Eyes June Product Revenue — May 14, 2026
Daré Bioscience’s Ovaprene Trial Yields 9% Pregnancy Rate, 12% Discontinuations — May 12, 2026
Daré Bioscience Launches DARE to PLAY Cream, Eyes Q2 2026 Revenue — Mar 26, 2026
Dare Bioscience Forecasts $0.38M Q4 Revenue, Sees 690% Price Upside — Mar 25, 2026

Common questions about DARE

What do analysts rate DARE?: 2 analysts cover DARE: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $10.00.
Does Rallies show DARE price targets?: Yes. Rallies tracks DARE analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is DARE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for DARE. It does not provide personalized investment advice.